GWM
PRSP

Geneos Wealth Management’s Perspecta Inc. Common Stock PRSP Stock Holding History

Geneos Wealth Management’s Portfolio PRSP Stock Details PRSP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-513
Closed -$15K – 3203
2021
Q1 		$15K Hold
513
– – ﹤0.01% 2225
2020
Q4 		$14K Sell
513
-108
-17% -$2.32K ﹤0.01% 2102
2020
Q3 		$11K Sell
621
-187
-23% -$3.95K ﹤0.01% 1932
2020
Q2 		$17K Sell
808
-3
-0.4% -$65 ﹤0.01% 1709
2020
Q1 		$15K Hold
811
– – ﹤0.01% 1642
2019
Q4 		$21K Buy
811
+17
+2% +$453 ﹤0.01% 1680
2019
Q3 		$20K Sell
794
-76
-9% -$1.86K ﹤0.01% 1618
2019
Q2 		$20K Buy
870
+51
+6% +$1.15K ﹤0.01% 1644
2019
Q1 		$16K Sell
819
-4
-0.5% -$80 ﹤0.01% 1683
2018
Q4 		$13K Sell
823
-9
-1% -$199 ﹤0.01% 1710
2018
Q3 		$21K Sell
832
-515
-38% -$12K ﹤0.01% 1561
2018
Q2 		$27K Buy
+1,347
New +$30.2K ﹤0.01% 1337

Other funds holding PRSP

KC
Kellner Capital New York $55.5M AUM 88.05% 1-Year Est. Return
EBSAM
Eubel Brady & Suttman Asset Management Miamisburg, Ohio $842M AUM 17.25% 1-Year Est. Return

Geneos Wealth Management's PRSP Position: Q2 2021 in Review

Geneos Wealth Management sold out of Perspecta Inc. Common Stock (PRSP) in Q2 2021, closing a stake of 513 shares — an estimated $15K sold.

Geneos Wealth Management first reported a position in PRSP in Q2 2018 and held it in 12 quarters. The position peaked at $27K in Q2 2018. 2 funds tracked by Wall St. Rank hold PRSP as of Q2 2021.

  • Geneos Wealth Management reported no remaining Perspecta Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
  • Geneos Wealth Management sold 513 Perspecta Inc. Common Stock shares in Q2 2021, an estimated $15K.
  • Geneos Wealth Management first reported a position in Perspecta Inc. Common Stock in Q2 2018 and held it in 12 quarters.
  • Geneos Wealth Management's Perspecta Inc. Common Stock position peaked at $27K in Q2 2018.
  • 2 funds tracked by Wall St. Rank held Perspecta Inc. Common Stock as of Q2 2021.

Based on Geneos Wealth Management's 13F filing for Q2 2021, filed 8 Jul 2021.